NU Logo
Bouve Logo
     Home      About Us      Campus Map      Site Map      Contact Us     
 

richard c. deth

Home > Faculty > Deth
  Professor

Contact Information
   Office: 312 Mugar Hall
   Voice: 617.373.4064
   Fax: 617.373.8886
   Email: r.deth@neu.edu

Education
Ph.D. University of Miami
B.S., State University of New York, Buffalo

Specializations
Pharmacology

Richard Deth

Major Research Areas
Role of D4 dopamine receptors in schizophrenia and attention

My research focus has been directed toward understanding the molecular basis of transmembrane signaling by G protein-coupled receptors. This includes the study of their structure using three-dimensional molecular graphics and modeling how the binding of various drugs causes a shift in their conformational state. We are particularly interested in the spontaneous activity exhibited by some receptors. In the case of D4 dopamine receptors we have characterized their conformation-dependent participation in the process of phospholipid methylation, a unique and novel mechanism of signaling. A cycle of D4 receptor-mediated phospholipid methylation requires resupply of a new methyl group from the single carbon folate pool, thereby linking activity of the D4 receptor to folate-dependent pathways of cellular metabolism. Different methylation states of the D4 receptor exhibit various degrees of spontaneous activity with regard to G protein coupling. Deficits in D4 receptor-mediated phospholipid methylation may contribute to the etiology of several neuropsychiatric disorders, including schizophrenia and depression.

Selected Publications
Deth, R.C. “Molecular Origins of Attention: The Dopamine-Folate Connection” Kluwer Academic Publishers (2003)

Zhu Q., Qi, L-J., Abou-Samra, A., Shi, A. and Deth, R.C.: “Protein kinase C-dependent constitutive activity of a2A/D-adrenergic receptors.” Pharmacol. 71: 80-90 (2004).

Waly, M., Banerjee, R., Choi, S.W., Mason, J., Benzecry, J., Power-Charnitsky, V.A, Deth, R.C. “PI3-kinase regulates methionine synthase: Activation by IGF-1 or dopamine and inhibition by heavy metals and thimerosal” Molecular Psychiatry 9: 358-370 (2004).

 

 

  [Top of Page]  

Department of Pharmaceutical Sciences, Northeastern University, Boston, MA 02115